FDA to review Pfizer vaccine on Dec. 10
The U.S. Food and Drug Administration announced Thursday that its vaccine advisory committee will meet Dec. 10 to discuss the request for emergency use authorization of Pfizer's COVID-19 vaccine candidate.
The public meeting will be a chance for both FDA career scientists and members of the independent advisory board to ask Pfizer questions about its product.
After that, the board will make a recommendation, which the FDA will take into account when it decides whether to authorize the vaccine.
Officials said they cannot predict how long the FDA's review will take, but that it will be "as expeditiously as possible, while still doing so in a thorough and science-based manner."
ABC News' Anne Flaherty contributed to this report